Therapists» attachment styles and previous personal relationship histories have also been shown to affect
therapeutic outcomes in that secure therapists are able to challenge both avoidant and anxious / ambivalent clients in a sensitive and timely way.
«They also suggest that low - dose metronomic chemotherapy or targeting the chemokine signaling mediated by chemo - treated fibroblasts may improve
the therapeutic outcome in desmoplastic cancers.»
Not exact matches
Four motifs
in Rogers» approach to counseling and therapy represent continuing contributions to the psychotherapeutic enterprise — his growth orientation; his emphasis on listening responsively and acceptingly to clients; his awareness that the emotional quality of the
therapeutic relationship is the key to whether or not it nurtures growth; and his commitment to subjecting the
therapeutic process and
outcome to careful research.
• Addressing latch issues immediately to prevent nipple pain and early weaning • Differentiating between Raynaud's Phenomenon of the Nipple and Candidiasis as a cause of pain • Evidence - based treatment strategies for painful nipples • Lanolin use and possible increased risk of nipple or breast infection • Topical treatments used by mothers for nipple pain and trauma • Frenotomy to decrease breastfeeding difficulties due to ankyloglossia • Timing of frenotomy for improved breastfeeding and infant
outcomes • Kinesio Elastic
Therapeutic Taping ®
in treating breast engorgement • Mothers» subjective experience of nipple pain and breastfeeding difficulties
«This gives us an underlying candidate biomarker panel that provides information on the subsequent clinical
outcome or
therapeutic efficacy, which can be validated to yield a final panel, then translated into say, an ELISA - based kit or some other immunodiagnostic format
in the clinical setting,» says Dorfman.
«These results should enable predictions of better clinical
outcomes with
therapeutic nonsense suppression,» the researchers write
in their paper.
If, however, you are more interested
in research you could become a health
outcomes researcher, collecting data on
therapeutic interventions for drug companies, or there is the Scientists Training Programme offered by the NHS.
In anticipation of targeted medicines, pharmaceutical and biotechnology companies are increasingly performing genetic studies of clinical trial participants in hopes of identifying genetic profiles that predict therapeutic outcome
In anticipation of targeted medicines, pharmaceutical and biotechnology companies are increasingly performing genetic studies of clinical trial participants
in hopes of identifying genetic profiles that predict therapeutic outcome
in hopes of identifying genetic profiles that predict
therapeutic outcomes.
«If we can understand how the antidepressant causes adverse metabolic
outcomes in the offspring than we can design
therapeutic strategies to prevent the damage while allowing women who require these drugs to be treated but reduce the potential harm to the offspring.»
«Importantly, the team was able to identify several genes that may be able to help us to predict
outcomes in certain circumstances or serve as good candidates for
therapeutic efforts.»
The study, which will be published December 21
in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes breast cancers more aggressive and resistant to chemotherapy, but points the way toward new
therapeutic approaches that could improve patient
outcome by preserving p53 levels.
«These are the best - done and largest assessments of how the microbiome may influence
therapeutic outcome» from those drugs, says immunotherapy researcher Jeffrey Weber of New York University
in New York City, who was not involved
in the studies.
«Our study found no evidence that there was improved survival or better functional
outcome with
therapeutic hypothermia compared to actively maintaining a normal temperature
in infants and children experiencing cardiac arrest
in a hospital.»
The paper, by S.S. Karuppagounder at Burke Medical Research Institute
in White Plains, N.Y., and colleagues was titled, «
Therapeutic targeting of oxygen - sensing prolyl hydroxylases abrogates ATF4 - dependent neuronal death and improves
outcomes after brain hemorrhage
in several rodent models.»
Interestingly, the team showed that combining anti-angiogenic and immune - stimulating therapies
in the treatment of tumors
in mouse models resulted
in better
therapeutic outcomes by providing white blood cell gates through which they can infiltrate cancers.
«Use of
therapeutic hypothermia and
outcomes following
in - hospital cardiac arrest.»
«These events predict a worse
outcome in TNBC patients suggesting that the LINK - A pathway plays a critical role
in this disease and may provide wide - ranging
therapeutic treatment targets.»
As such, novel
therapeutic interventions are needed to protect the heart from injury and improve clinical
outcomes in this patient group,» Hausenloy said.
In addition to her expert skill as a clinician, Dr. Frontera also has many research interests including identifying biomarkers and predictors of early brain injury and vasospasm / delayed cerebral ischemia after subarachnoid hemorrhage and their impact on outcome; determining the efficacy of therapeutic strategies and developing guidelines for the management of patients with intracranial hemorrhage; evaluating the cost, length of stay, quality of life, functional and cognitive outcomes in a broader population of intracranial hemorrhage patients; developing guidelines for the integration of palliative care into the intensive care unit setting; and evaluating the relationship of Zika virus infection, Guillain - Barre, and other neurologic disorder
In addition to her expert skill as a clinician, Dr. Frontera also has many research interests including identifying biomarkers and predictors of early brain injury and vasospasm / delayed cerebral ischemia after subarachnoid hemorrhage and their impact on
outcome; determining the efficacy of
therapeutic strategies and developing guidelines for the management of patients with intracranial hemorrhage; evaluating the cost, length of stay, quality of life, functional and cognitive
outcomes in a broader population of intracranial hemorrhage patients; developing guidelines for the integration of palliative care into the intensive care unit setting; and evaluating the relationship of Zika virus infection, Guillain - Barre, and other neurologic disorder
in a broader population of intracranial hemorrhage patients; developing guidelines for the integration of palliative care into the intensive care unit setting; and evaluating the relationship of Zika virus infection, Guillain - Barre, and other neurologic disorders.
We hope that these efforts will allow us to identify means by which the response of iNKT cells can be manipulated to effect desired immunologic
outcomes in possible
therapeutic applications.
Although improvements
in therapeutic strategies were achieved, the
outcome remains poor for most patients with metastatic or recurrent osteosarcoma.
While translational research has traditionally moved basic immunology knowledge forward into clinical application, varying clinical presentations of human immune - related disease processes, as well as variability
in therapeutic outcomes, have provided opportunities for discovery of novel mechanistic hypotheses directly from patients.
Dose and temporal pattern of estrogen exposure determines neuroprotective
outcome in hippocampal neurons:
therapeutic implications.
In general, genetic polymorphisms result in alterations of pharmacokinetic and / or pharmacodynamics properties which are then reflected in therapy outcomes that range from potentially life - threatening adverse effects to inadequate therapeutic respons
In general, genetic polymorphisms result
in alterations of pharmacokinetic and / or pharmacodynamics properties which are then reflected in therapy outcomes that range from potentially life - threatening adverse effects to inadequate therapeutic respons
in alterations of pharmacokinetic and / or pharmacodynamics properties which are then reflected
in therapy outcomes that range from potentially life - threatening adverse effects to inadequate therapeutic respons
in therapy
outcomes that range from potentially life - threatening adverse effects to inadequate
therapeutic response.
Recent progress
in biochemistry and pathophysiology has enabled search for novel diagnostic markers and
therapeutic targets to improve cardiovascular
outcomes globally.
One secondary
outcome will be immunogenicity, meaning monitoring subjects for any emergence of antibodies against the infused
therapeutic antibodies themselves; additionally, «Multiple clinical and exploratory biomarkers will be assessed»
in the Phase Ib trial.
Amyotrophic lateral sclerosis (ALS) is caused by massive motor neuron death and, as pre ‐ clinical data have failed to translate into better
outcomes in clinical trials [1], stem cell trials have been conducted to find alternative
therapeutic solutions.
«PROs supplement clinical
outcomes and provide a holistic understanding of patient experience and treatment effectiveness, and help inform
therapeutic choices, disease management practices, reimbursement decisions, and health policy,» said Dirk Schadendorf, MD, director of the department of dermatology at the University Hospital Essen
in Essen, Germany.
The significant difference
in outcome achieved by transplantation of hGDAsBMP versus hGDAsCNTF demonstrates clearly that not all astrocytes are equivalent
in respect to their
therapeutic value, and this appears to be the first study demonstrating functional differences between different human astrocyte populations with respect to repairing the adult central nervous system.
Previous studies have linked gene expression profiles
in bCSCs with a clinical
outcome [1, 2], and
in this study the authors have extended this out to demonstrate that a DNA methylation profile may promote these changes, and furthermore, that this profile can be effectively used to predict prognosis, and potentially aid the
therapeutic decision making.
These pre-clinical results are encouraging and demonstrate a fascinating approach to bringing improved patient
outcomes that would enable rapid advances
in precision medicine and
therapeutic stratification
in the future.»
â $ œFor the first time, a clinical trial has shown that administration of a cellular
therapeutic results
in an improvement
in cardiac
outcomes based on a prespecified analysis, â $ an editorial accompanying the paper
in The Lancet says.
Their work points to opportunities for
therapeutic interventions — even
in the first few weeks of life — that might improve long - term
outcomes for the preemies.
Dr. Lanteri is also interested
in using the OMICS approach to identify predictive markers of disease
outcome and new
therapeutic targets.
In 1954, an era where only 5 % of patients with Hodgkin lymphoma survived, Drs. Henry Kaplan and Edward Ginzton invented the first medical linear accelerator in the Western Hemisphere to deliver therapeutic radiotherapy (RT) with improved accuracy and potency, leading to curative outcomes in a group of patients with Hodgkin lymphom
In 1954, an era where only 5 % of patients with Hodgkin lymphoma survived, Drs. Henry Kaplan and Edward Ginzton invented the first medical linear accelerator
in the Western Hemisphere to deliver therapeutic radiotherapy (RT) with improved accuracy and potency, leading to curative outcomes in a group of patients with Hodgkin lymphom
in the Western Hemisphere to deliver
therapeutic radiotherapy (RT) with improved accuracy and potency, leading to curative
outcomes in a group of patients with Hodgkin lymphom
in a group of patients with Hodgkin lymphoma.
The extraordinary and welcome growth
in interest
in novel
therapeutic platforms, including
in cell based immunotherapies, has the potential to transform patient
outcomes in a range of acute and chronic diseases.
Breast cancer is a heterogeneous disease with a high degree of diversity
in histology,
therapeutic response, and treatment
outcomes.
Recently, more researchers have applauded self - massage,
in particular, with a new study published
in the International Journal of
Therapeutic Massage Bodywork finding that it significantly improves the
outcome of those with osteoarthritis of the knee.
However, far from encouraging people to consume unhealthy fats, this promising
outcome may result
in new
therapeutic uses of Incas» peanut for the treatment of both hypertriglyceridemia and type 2 diabetes, as well as
in new ways of preventing cardiovascular and metabolic diseases.
When these techniques are used
in conjunction with
therapeutic exercises, patient
outcomes are greatly improved.
Class IV lasers are a non-invasive, drug - free solution that offers better patient
outcomes in a myriad of surgical and
therapeutic applications.
My duties include effectively manages programs and teams ensuring the program is meeting expected
outcomes and review data accordingly; accomplished by placing
therapeutic foster children
in resource family homes.
Tags for this Online Resume: clinical, affairs, scientific, trials, innovative, management, summary, documents, submission, regulatory, 510 (k), ISE, ISS, PK / PD, communicating, monitoring, tactical, strategic, literature, direct, vision, Lead, Director, documentation, resources, execution, consensus, effectiveness, safety, CRA, IVD, medical, device, pharmaceutical, presentation, manuscript, abstract, poster, programs, leadership, career, development, appraisals, optimize, goals, objectives, internal, external, research, investigator, stakeholders, customers, prioritize, product, support, milestones, Microsoft, Word, Excel, statistics, data, analysis, Powerpoint, publication, growth, deliverables, diagnostic, prognostic, treatment, competitive, proven, ability, capable, assess, strategy, feasibility, methodology, design, develop, produce, recommend, recommendation,
therapeutic, supervision, review, performance, appraisal, application, indication, company, collaborate, expert, justification, senior, executive, assessment, experienced, marketing, pre-market, pre-IDE, protocol, communication, utility, pharmacology, service, deliver, delivery, drug, metabolism, absorption, excretion, train, training, mentor, mentoring, CRO, reimbursement, XLSTAT, Prism, relationship, contract, consult, consultant, ownership, responsibility, authority, delegate, trends, direction,
in - vitro, commercialize, commercialization, approval, clearance, patient, oncology, cancer, metabolic, cardiovascular, kidney, disease, health,
outcomes, safe, effective, toxicity, novel, unique, unmet, need, advisors, advisory, committee, IRB, ethical, justified, supportive, care, associate
Therapeutic and restorative processes, such as Koori and Murri courts, drugs courts and healing circles, are ways
in which the criminal justice system can help to rebuild relationships and deliver positive
outcomes for the entire community.
Day 1 will focus on how to uncover, amplify and diagnose strengths, resources, and positive attributes
in a client's life that are critical for a positive
therapeutic outcome, while also strengthening the
therapeutic alliance.
Relationship factors and therapy While current
outcome research indicates that
therapeutic relationship factors account for 30 % of client change
in talk therapies, the implication is that these relationship factors are operative
in relationships outside of talk therapy sessions.
Ethnocultural differences
in therapeutic alliance and
outcome for women with comorbid posttraumatic stress disorder and substance use disorder.
Therapeutic alliance
in post-acute brain injury rehabilitation: Predictors of strength of alliance and impact of alliance on
outcome: Brain Injury Vol 21 (7) Jun 2007, 663 - 672.
The
therapeutic relationship and active engagement
in recovery acted as mediators of the
outcome throughout each stage of the process.
Therefore, the simple amount of
therapeutic contact is not a viable explanation for differences
in outcome between DBT and CTBE.